“METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): DIAGNOSTIC CRITERIA AND EMERGING PHARMACOTHERAPY ”, ITFTTDM, vol. 4, no. 9, pp. 129–31, Sep. 2026, Accessed: Oct. 10, 2026. [Online]. Available: https://universalpublishings.com/index.php/itfttdm/article/view/20686